ARA-290 is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to activate the body’s innate repair receptor (IRR) without stimulating red blood cell production. This modification allows researchers to study its anti-inflammatory, tissue-protective, and neuroprotective properties without the hematopoietic effects associated with EPO.
In research settings, ARA-290 has been explored for its role in cellular repair signaling, inflammation modulation, and nerve function support. Its unique mechanism makes it of interest in studies related to neuropathic pain, metabolic health, and inflammatory conditions.
Non-hematopoietic EPO-derived peptide
Activates the innate repair receptor (IRR)
Studied for anti-inflammatory signaling pathways
Investigated for nerve and tissue protection
Does not increase hematocrit or red blood cell count
